Provident Investment Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-82,099
Closed -$24.7M 55
2018
Q4
$24.7M Sell
82,099
-2,562
-3% -$818K 4.41% 11
2018
Q3
$29.9M Sell
84,661
-2,505
-3% -$862K 4.25% 13
2018
Q2
$25.3M Buy
87,166
+4,336
+5% +$1.22M 3.59% 17
2018
Q1
$22.7M Buy
82,830
+15,874
+24% +$4.93M 3.58% 18
2017
Q4
$21.3M Buy
66,956
+472
+0.7% +$151K 3.41% 18
2017
Q3
$20.8M Buy
66,484
+128
+0.2% +$37.9K 3.53% 19
2017
Q2
$18M Buy
66,356
+1,044
+2% +$276K 3.28% 19
2017
Q1
$17.9M Sell
65,312
-145
-0.2% -$41K 3.32% 19
2016
Q4
$18.6M Sell
65,457
-444
-0.7% -$132K 3.6% 18
2016
Q3
$20.6M Sell
65,901
-189
-0.3% -$56K 4.28% 14
2016
Q2
$16M Buy
66,090
+1,191
+2% +$314K 3.29% 19
2016
Q1
$16.9M Buy
64,899
+3,004
+5% +$794K 3.38% 18
2015
Q4
$19M Buy
61,895
+10,645
+21% +$3.06M 3.81% 16
2015
Q3
$15M Buy
+51,250
New +$16.9M 3.13% 16

Other funds holding BIIB

Provident Investment Management's BIIB Position: Q1 2019 in Review

Provident Investment Management sold out of Biogen (BIIB) in Q1 2019, closing a stake of 82,099 shares — an estimated $24.7M sold.

Provident Investment Management first reported a position in BIIB in Q3 2015 and held it in 14 quarters. The position peaked at $29.9M in Q3 2018. 1,085 funds tracked by Wall St. Rank hold BIIB as of Q1 2019.

  • Provident Investment Management reported no remaining Biogen position as of Q1 2019 after selling out during the quarter.
  • Provident Investment Management sold 82,099 Biogen shares in Q1 2019, an estimated $24.7M.
  • Provident Investment Management first reported a position in Biogen in Q3 2015 and held it in 14 quarters.
  • Provident Investment Management's Biogen position peaked at $29.9M in Q3 2018.
  • 1,085 funds tracked by Wall St. Rank held Biogen as of Q1 2019.

Based on Provident Investment Management's 13F filing for Q1 2019, filed 13 May 2019.